Follow
Ariel Isser
Title
Cited by
Cited by
Year
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity
CA Bessell, A Isser, JJ Havel, S Lee, DR Bell, JW Hickey, ...
JCI insight 5 (8), 2020
1082020
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy
A Isser, NK Livingston, JP Schneck
Biomaterials 268, 120584, 2021
452021
Rapid expansion of highly functional antigen-specific T cells from patients with melanoma by nanoscale artificial antigen-presenting cells
J Ichikawa, T Yoshida, A Isser, AS Laino, M Vassallo, D Woods, S Kim, ...
Clinical Cancer Research 26 (13), 3384-3396, 2020
312020
Collagen fiber architecture regulates hypoxic sarcoma cell migration
DM Lewis, V Tang, N Jain, A Isser, Z Xia, S Gerecht
ACS Biomaterials Science & Engineering 4 (2), 400-409, 2018
292018
Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties
JW Hickey, AY Isser, FP Vicente, SB Warner, HQ Mao, JP Schneck
Biomaterials 187, 105-116, 2018
242018
Biodegradable cationic polymer blends for fabrication of enhanced artificial antigen presenting cells to treat melanoma
KR Rhodes, A Isser, JW Hickey, E Ben-Akiva, RA Meyer, AK Kosmides, ...
ACS applied materials & interfaces 13 (7), 7913-7923, 2021
232021
Adaptive nanoparticle platforms for high throughput expansion and detection of antigen-specific T cells
JW Hickey, A Isser, SF Salathe, KM Gee, MH Hsiao, W Shaikh, ...
Nano letters 20 (9), 6289-6298, 2020
182020
Cross-reactivity of SARS-CoV-2–and influenza A–specific T cells in individuals exposed to SARS-CoV-2
W Chaisawangwong, H Wang, T Kouo, SF Salathe, A Isser, JG Bieler, ...
JCI insight 7 (18), 2022
102022
Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy
E Ben-Akiva, JW Hickey, RA Meyer, A Isser, SR Shannon, NK Livingston, ...
Acta Biomaterialia 160, 187-197, 2023
72023
Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy
A Isser, AB Silver, HC Pruitt, M Mass, EH Elias, G Aihara, SS Kang, ...
Nature communications 13 (1), 6086, 2022
62022
High-affinity T cell receptors for adoptive cell transfer
A Isser, JP Schneck
The Journal of Clinical Investigation 129 (1), 69-71, 2019
22019
A conserved MART-1 T cell receptor motif is predictive of responses to checkpoint blockade
A Isser, T Yoshida, J Ichikawa, J Weber, J Schneck
JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019
12019
1215 Using nanoparticles as artificial antigen presenting cells to activate human CD4 T cells for immunotherapy
SS Kang, A Isser, J Schneck
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
Adaptive nanoparticle platforms for high throughput expansion and detection of antigen-specific t cells
J Schneck, H Mao, JW Hickey, A Isser
US Patent App. 18/011,070, 2023
2023
Using nanoparticles as artificial antigen presenting cells to mobilize CD4 T cells for immunotherapy.
SS Kang, A Isser, JP Schneck
The Journal of Immunology 210 (1_Supplement), 250.12-250.12, 2023
2023
TARGETING CD4 T CELLS WITH NANOTECHNOLOGY FOR ENHANCED CANCER IMMUNOTHERAPY
AY Isser
Johns Hopkins University, 2022
2022
Cross Reactivity of CD8+ T Cell Neo-epitopes to Bifidobacterium Boosts the Tumor Specific Population
CA Bessell, A Isser, J Havel, T Chan, JP Schneck
The Journal of Immunology 200 (1_Supplement), 57.33-57.33, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–17